Cancer BiologyCancer ResearchPeer-reviewed
VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment.
Tenzin Passang, Shuhua Wang, Hanwen Zhang…·Edmund K. Waller
This study shows that VPAC2 receptor signaling in pancreatic cancer cells promotes tumor growth and reduces immunogenicity, suggesting it as a therapeutic target.